PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-29

Date Title Company
01-Mar-2024 Biogen needs Leqembi to be successful following discontinuation of Aduhelm, says GlobalData GlobalData
01-Mar-2024 Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations Evaxion
29-Feb-2024 Beyond the Illusion: Ever Dreamed of Escaping the Matrix? Dive Into Dr. Isaac J. Sun's New Book 'The Earth's Matrix: The Code of Human Life' AccessWire
29-Feb-2024 enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update AccessWire
29-Feb-2024 Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers AccessWire
29-Feb-2024 Netsmart Achieves the Top Technology Solutions Rating in Rehabilitation and Physical Therapy Software, Black Book 2024 EHR User Survey AccessWire
29-Feb-2024 BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives BRAIN Biotech AG
29-Feb-2024 BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights BRAIN Biotech AG
29-Feb-2024 On Rare Disease Day, Q4HE Collaboration Highlights Purpose in Action AccessWire
29-Feb-2024 Q-Linea joins forces with Uniphar Logistics in Raleigh, NC AccessWire
29-Feb-2024 Abingworth Announces a Strategic Development Financing Agreement with Gilead Sciences Establishes Joint Steering Committee between Launch Therapeutics and Gilead Sciences Abingworth
29-Feb-2024 Coave Therapeutics Receives Grant from the ALS Association to Advance its CTx-TFEB Program as a Potential Treatment for All Forms of ALS Coave Therapeutics
29-Feb-2024 ASLAN PHARMACEUTICALS RECEIVES FAVORABLE OPINION FROM THE EUROPEAN PATENT OFFICE ON COMPOSITION OF MATTER PATENT APPLICATION FOR FARUDODSTAT ASLAN PHARMACEUTICALS
29-Feb-2024 Leading biotech awarded second FDA Orphan Drug Designation to boost search for rare disease therapies SynaptixBio
29-Feb-2024 1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures AccessWire
29-Feb-2024 Powerhouses QCCA and NCCA Merge to Create a Transformative New Entity in Independent Practice Oncology and Cancer Care: ONCare Alliance, LLC AccessWire
29-Feb-2024 Sequani invests in industry leading facilities as it eyes future growth Sequani
29-Feb-2024 Coave Therapeutics Receives Grant from the ALS Association to Advance its CTx-TFEB Program as a Potential Treatment for All Forms of ALS Coave Therapeutics
29-Feb-2024 National Institute for Health and Care Excellence (NICE) recommends first licensed treatment for newly diagnosed systemic amyloid light-chain (AL) amyloidosis National Institute for Health and Care Excellence (NICE)
29-Feb-2024 Ariceum Therapeutics Granted UK Authorisation to Conduct Phase I Clinical Study of its First-in-Class Iodine-123 Labelled PARP Inhibitor in Patients with Recurrent Glioblastoma Ariceum Therapeutics